Cologuard Plus
Prescription multitarget stool-based colorectal cancer screening test for average-risk adults age 45 years or older.
- Developer
- Exact Sciences
- Intended use
- Screening
- Cancer scope
- Not reported
- Specimen
- Stool
- Molecular modality
- DNA methylation, Protein
- Current version
- Cologuard Plus P230043/S010 current FDA lineage snapshot
- Evidence context
- 1 structured studies · 14 indexed performance results · 15 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.